A North Carolina drugmaker pushing the development of a potential Covid-19 treatment has the first analysis of its drug in a peer-reviewed journal — and the results are good. Results from the first patients treated with Raleigh's RedHill (NASDAQ: RDHL) drug, opaganib, were published in medRxiv. The analysis concerns patients treated in Israel, which approved the drug for compassionate use in the early days of the pandemic. According to the study, seven patients with "severe Covid-19" who required…
from Charlotte Business News - Local Charlotte News | Charlotte Business Journal https://www.bizjournals.com/charlotte/news/2020/06/29/covid-19-treatment-shows-patient-improvement.html?ana=RSS&s=article_search
No comments:
Post a Comment